Viewpoint has selected the University of Iowa BioVentures Center, located at 2500 Crosspark Rd, Coralville, IA 52241, as the location to expand laboratory operations. The BioVentures Center facilities are uniquely designed and operated for biotechnology start-up companies and Viewpoint is delighted to have grown into these new laboratory facilities.
Our management team is comprised of Viewpoint founders and a growing team of experienced advisors who are committed to growing the company as a global leader discovery engine focused on the development of personalized image-guided therapies for cancer. Viewpoint is growing the company through an aggressive schedule of non-dilutive funding proposals to federal agencies, combined with other sources of capital investment.
The management and advisor teams at Viewpoint bring years of business experience and detailed scientific understanding of its products. Viewpoint intends to lead the industry in the development of targeted alpha-particle therapies and companion products for cancer and to introduce its novel products to the health care system for the benefit of patient care.
Viewpoint Molecular Targeting, Inc.
2500 Crosspark Rd
Coralville, IA 52241
JTC Team, LLC